000 | 01052 a2200301 4500 | ||
---|---|---|---|
005 | 20250517123600.0 | ||
264 | 0 | _c20180921 | |
008 | 201809s 0 0 eng d | ||
022 | _a1784-3227 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGondal, B | |
245 | 0 | 0 |
_aImmune--Mediated Colitis with Novel Immunotherapy : PD-1 Inhibitor Associated Gastrointestinal Toxicity. _h[electronic resource] |
260 |
_bActa gastro-enterologica Belgica _c |
||
300 |
_a379-381 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aColitis _xchemically induced |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
700 | 1 | _aPatel, P | |
700 | 1 | _aGallan, A | |
700 | 1 | _aHart, J | |
700 | 1 | _aBissonnette, M | |
773 | 0 |
_tActa gastro-enterologica Belgica _gvol. 79 _gno. 2 _gp. 379-381 |
|
999 |
_c26583812 _d26583812 |